| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965775 | Vaccine | 2014 | 7 Pages |
Abstract
The CHP-MAGE-A4 vaccine was safe. Expression of MAGE-A4 and MHC class I in tumor tissue and the induction of a MAGE-A4-specific immune response after vaccination would be feasible prognostic markers for patients vaccinated with MAGE-A4.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Takuro Saito, Hisashi Wada, Makoto Yamasaki, Hiroshi Miyata, Hiroyoshi Nishikawa, Eiichi Sato, Shinichi Kageyama, Hiroshi Shiku, Masaki Mori, Yuichiro Doki,